Biomet shareholders approve acquisition 9-to-1

September 5, 2007
Biomet's $11.4 billion acquisition by a group of private-equity firms has been accepted by shareholders, the Warsaw prosthetics company said today.

More than 91 percent of shares voted were in favor of the deal with The Blackstone Group, Goldman, Sachs & Co., Kohlberg Kravis Roberts & Co. and TPG.

Closing is expected this month.
Source: XMLFULL/XMLFull3989.xml

Recent Articles by IBJ Staff

Comments powered by Disqus